This Option Care Health Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday
Analysts downgraded PJT, OPCH, CRBU, ABEV , cutting price targets for PJT, CRBU.
Stocks · News reference
RBC Capital Downgrades Caribou Biosciences to Sector Perform, Lowers Price Target to $1
RBC Capital analyst Luca Issi downgrades Caribou Biosciences (NASDAQ:CRBU) from Outperform to Sector Perform and lowers the price target from $10 to $1.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Brookline Capital Downgrades Caribou Biosciences to Hold
Brookline Capital analyst Leah Cann downgrades Caribou Biosciences (NASDAQ:CRBU) from Buy to Hold.
Dow Tumbles 350 Points; Constellation Brands Earnings Top Views
U.S. stocks fell Wednesday; Dow dropped 350 points. Energy rose, materials slid. Constellation beat estimates; oil gained while gold and silver fell.